daporinad   Click here for help

GtoPdb Ligand ID: 7745

Synonyms: APO-866 | FK-866 | FK866
PDB Ligand
Compound class: Synthetic organic
Comment: FK866 is a highly specific non-competitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT; P43490) [2], an enzyme required for the biosynthesis of nicotinamide adenine dinucleotide (NAD+).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 10
Topological polar surface area 62.3
Molecular weight 391.23
XLogP 3.83
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(C=Cc1cccnc1)NCCCCC1CCN(CC1)C(=O)c1ccccc1
Isomeric SMILES O=C(/C=C/c1cccnc1)NCCCCC1CCN(CC1)C(=O)c1ccccc1
InChI InChI=1S/C24H29N3O2/c28-23(12-11-21-8-6-15-25-19-21)26-16-5-4-7-20-13-17-27(18-14-20)24(29)22-9-2-1-3-10-22/h1-3,6,8-12,15,19-20H,4-5,7,13-14,16-18H2,(H,26,28)/b12-11+
InChI Key KPBNHDGDUADAGP-VAWYXSNFSA-N
Bioactivity Comments
Daporinad (FK866) inhibits NAMPT with an Ki value of 0.4nM [2]. In vitro treatment of patient-derived chronic lymphocytic leukemia (CLL) cells with daporinad induces apoptotic cell death via depletion of NAD+ [1], and may offer an additional clinical tool to combat this currently incurable disease.